Financiere de Tubize (LTS:0D53) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Financiere de Tubize Days Sales Outstanding?

Financiere de Tubize's average Accounts Receivable for the six months ended in Dec. 2023 was €0.00 Mil. Financiere de Tubize's Revenue for the six months ended in Dec. 2023 was €0.00 Mil.

The historical rank and industry rank for Financiere de Tubize's Days Sales Outstanding or its related term are showing as below:

LTS:0D53's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.34
* Ranked among companies with meaningful Days Sales Outstanding only.

Financiere de Tubize's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Financiere de Tubize Days Sales Outstanding Historical Data

The historical data trend for Financiere de Tubize's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Financiere de Tubize Days Sales Outstanding Chart

Financiere de Tubize Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

Financiere de Tubize Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Financiere de Tubize's Days Sales Outstanding

For the Biotechnology subindustry, Financiere de Tubize's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Financiere de Tubize's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's Days Sales Outstanding falls into.

Financiere de Tubize Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Financiere de Tubize's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Financiere de Tubize's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

Financiere de Tubize (LTS:0D53) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Financiere de Tubize Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Financiere de Tubize's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Financiere de Tubize (LTS:0D53) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Financiere de Tubize SA (LTS:0D53) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

TUB:Belgium

Address

Allée de la Recherche, 60, Brussels, BEL, 1070

Website

https://www.financiere-tubize.be

Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a global biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Most of its sales revenue is derived from its neurology products, followed by its immunology products. The company's strategy focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Financiere de Tubize (LTS:0D53) Headlines

No Headlines